Moximed Raises $40 Million to Support the MISHA Knee System

Moximed secured $40 million in Series C equity and debt financing. Proceeds will be used to gain regulatory approvals and establish commercial infrastructure for the MISHA™ Knee System, reported to be the world’s first implantable shock absorber (ISA) for the knee.

Moximed utilized clinically established benefits of weight load reduction on...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us